Reston, VA, United States of America

Peter J Buontempo

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Leidos, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter J Buontempo. Retrieved from https://idiyas.com/inventor/peter-j-buontempo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peter J Buontempo

Introduction

Peter J Buontempo is an accomplished inventor based in Reston, VA (US). He has made significant contributions to the field of immunology through his innovative work on peptides. His research focuses on therapeutic applications that can address various health challenges.

Latest Patents

Peter J Buontempo holds a patent for immunomodulatory peptides. This patent provides peptides that can be utilized for multiple therapeutic purposes. These include inhibiting the progression of hyperproliferative disorders, such as cancer, treating infectious diseases, enhancing responses to vaccinations, treating sepsis, and promoting hair re-pigmentation or lightening pigmented skin lesions.

Career Highlights

Peter is currently employed at Leidos, Inc., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of immunotherapy.

Collaborations

Throughout his career, Peter has collaborated with notable colleagues, including Gabriel M Gutierrez and James Pannucci. These partnerships have further enriched his research and contributed to the success of his projects.

Conclusion

Peter J Buontempo's innovative work in immunomodulatory peptides showcases his dedication to advancing therapeutic solutions for critical health issues. His contributions are paving the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…